Panama Petrochem Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook

Panama Petrochem (NSE: PANAMAPET) is preparing to announce its Q4 FY26 financial results for the quarter ended March 31, 2026. With Panama Petrochem trading at Rs 315 — against a 52-week high of Rs 480 and a 1-year return of -25% — the Q4 FY26 results will be a pivotal event for investors tracking the Specialty Chemicals sector.

Analyst estimates for Q4 FY26 revenue stand at Rs 320–360 Cr, with PAT expectations of Rs 22–30 Cr and margin projections of EBITDA 9–12%. This article covers the Panama Petrochem Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings, and answers to the most commonly searched investor questions.

Get free investment predictions on Univest.

Panama Petrochem Q4 Results 2026 Date

Panama Petrochem has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet to approve audited financial statements for the quarter ended March 31, 2026, and to consider a final dividend recommendation. At a CMP of Rs 315, investors will closely watch this announcement for revenue growth confirmation and FY27 guidance.

Why This Quarter Matters

Q4 FY26 is the final quarter of the financial year — it determines full-year FY26 performance, sets the FY27 estimate base, and triggers final dividend announcements. For Panama Petrochem, operating in the Specialty Chemicals sector, Q4 will reveal whether earlier-quarter momentum has sustained and whether management’s strategic initiatives are delivering measurable financial outcomes.

At a 1-year return of -25%, the Q4 FY26 results and FY27 guidance commentary will be critical in determining whether the stock can recover toward its 52-week high of Rs 480. Investors will focus on order book updates, margin trajectory, and management tone — positive surprises on multiple parameters could drive a meaningful re-rating.

Panama Petrochem Q4 FY26 Earnings Estimates

Access premium SEBI-registered research on Univest.

Analysts covering Panama Petrochem have published Q4 FY26 estimates reflecting sector trends and company-specific catalysts. Consensus points to revenue of Rs 320–360 Cr, PAT of Rs 22–30 Cr, and margins of EBITDA 9–12%. These projections incorporate Q4 seasonal strength and ongoing business improvements.

Beyond headline numbers, investors should monitor FY27 guidance commentary, working capital trends, and order book visibility. A clean recurring profit print — rather than one inflated by non-operational items — carries greater weight with long-term investors.

Screen Panama Petrochem fundamentals on Univest Screener.

5 Key Factors That Will Drive Panama Petrochem Q4 FY26 Performance

Revenue Growth Drivers in Specialty Chemicals

Panama Petrochem’s Q4 FY26 revenue estimate of Rs 320–360 Cr reflects sector-level demand recovery and company-specific execution. Q4 is seasonally the strongest quarter for most Indian businesses due to year-end order execution and government spending acceleration. Panama Petrochem’s ability to capitalise on these tailwinds will depend on operational capacity, client relationships, and pricing power within its competitive landscape.

Margin Expansion and Operating Leverage

Panama Petrochem’s Q4 FY26 margin estimate of EBITDA 9–12% embeds expected improvement as fixed costs are absorbed over a growing revenue base. Smaller and mid-cap companies often demonstrate disproportionate EBITDA expansion when quarterly revenues scale even modestly. Management cost discipline — particularly on employee expenses, power, and overheads — will determine the degree of margin recovery.

Working Capital Management and Cash Conversion

For Panama Petrochem operating in the Specialty Chemicals segment, working capital efficiency is a critical determinant of financial health. Q4 FY26 results will reveal debtor days, inventory levels, and net cash conversion cycle. Any improvement in collections and receivables management would signal better business quality and reduce dependence on short-term borrowing.

FY27 Guidance and Business Pipeline

Management commentary on FY27 business outlook — however informally delivered for smaller companies — will be as important as Q4 headline numbers. New client wins, order book updates, geographic expansion plans, and product pipeline disclosures provide investors with forward visibility that shapes stock price trajectory into FY27.

Competitive Positioning and Market Share

Panama Petrochem’s Q4 FY26 performance reflects its ability to hold or gain competitive ground in the Specialty Chemicals sector. Market share stability, pricing power, and client retention metrics are the key qualitative indicators that separate sustainable performance from one-off beats. Any evidence of market share gains — however marginal — would be a strongly positive qualitative signal.

5 Risks to Watch in Panama Petrochem Q4 FY26

Macroeconomic Headwinds and Demand Risk

The April 2026 US tariff shock and global uncertainty have created headwinds for Indian equities through FII outflows and compressed demand in export-linked sectors. For Panama Petrochem, indirect impacts include input cost pressure, sentiment-driven selling, and potential softening of client capex budgets. Any deterioration in macro conditions for Q1 FY27 would require analyst estimate revisions.

Input Cost and Supply Chain Volatility

Panama Petrochem’s cost structure in the Specialty Chemicals space is exposed to raw material price movements and supply chain disruptions. Any reversal in the commodity price trends embedded in Q4 estimates — whether crude, metals, chemicals, or agricultural inputs — could compress gross margins and disappoint PAT expectations despite revenue in-line performance.

Competitive Pressure and Pricing Risk

The Specialty Chemicals sector is experiencing intensifying competition from both domestic and international players. Pricing pressure — whether from low-cost Chinese imports, domestic capacity additions, or client negotiation — could force Panama Petrochem to offer discounts or increase marketing spend, compressing margins below the Q4 FY26 estimate range.

Governance and Reporting Quality Risk

Panama Petrochem operates as a smaller listed entity with limited institutional investor scrutiny compared to large-cap peers. Investors should review auditor qualifications, related-party transactions, promoter pledging data, and contingent liabilities in the Q4 FY26 annual results before drawing conclusions about long-term investment merit.

FY27 Guidance Risk and Estimate Revision

If Panama Petrochem’s Q4 FY26 management commentary signals weaker-than-expected FY27 demand or margin compression, analyst estimate cuts would follow quickly given the limited coverage and thin investor base. The market’s reaction to guidance disappointment is typically sharper for smaller companies where sentiment can swing significantly on limited new information.

Panama Petrochem Share Price and Analyst Ratings

Panama Petrochem is trading at Rs 315 as of early April 2026, against a 52-week high of Rs 480 and 52-week low of Rs 265. Market cap stands at Rs 1,125 Cr. The 1-year return of -25% reflects sector headwinds alongside company-specific factors. Analyst price targets range from the conservative to the optimistic, reflecting differing views on recovery pace and FY27 earnings potential.

Download the Univest iOS App or Univest Android App to track Panama Petrochem’s live price and receive real-time Q4 result alerts.

Conclusion

Panama Petrochem Q4 FY26 results will reflect white mineral oil and petrochemical specialty demand from pharma, FMCG, and cosmetics clients. At Rs 315, the stock is 34% below its 52-week high. Revenue toward Rs 340 Cr with PAT above Rs 25 Cr would be positive. Export client pipeline commentary will be the key forward indicator. Consult a SEBI-registered advisor before investing.

This content is published by Univest, a SEBI-registered research and advisory platform. All analyst estimates and price targets cited are from publicly available broker notes. Past performance is not indicative of future results. Investors should conduct independent due diligence before making any investment decisions.

For more Q4 FY26 previews visit Univest Blogs.

Frequently Asked Questions

What is the Panama Petrochem Q4 results 2026 date?

Panama Petrochem Q4 FY26 results are scheduled for May 2026 (Expected). The board will meet to approve audited financial statements for the quarter ended March 31, 2026.

What is the Panama Petrochem Q4 FY26 PAT estimate?

Analysts estimate Panama Petrochem Q4 FY26 PAT in the range of Rs 22–30 Cr, on revenue of Rs 320–360 Cr and margin of EBITDA 9–12%. Actual results may differ from these estimates.

What is Panama Petrochem’s share price ahead of Q4 results?

Panama Petrochem shares are trading at approximately Rs 315 as of early April 2026. The 52-week high is Rs 480 and 52-week low is Rs 265. The one-year return is -25% and market cap stands at Rs 1,125 Cr.

Will Panama Petrochem declare a dividend in Q4 2026?

Panama Petrochem is expected to consider Rs 3–5 per share at the Q4 FY26 board meeting on May 2026 (Expected). The dividend decision reflects management’s confidence in FY26 free cash flow generation.

Which analysts have a Buy rating on Panama Petrochem?

MOFSL (target Rs 400), YES Securities (target Rs 420) ahead of Q4 FY26 results.

What were Panama Petrochem Q3 FY26 results?

In Q3 FY26, Panama Petrochem reported revenue of Rs 288 Cr and PAT of Rs 18 Cr with margins at EBITDA 10.5%. These provided the base for Q4 FY26 analyst estimates.

When do Infosys and TCS announce Q4 results 2026?

TCS announced Q4 FY26 results on April 9, 2026 — full preview at TCS Q4 Results 2026. Infosys announced results on April 23, 2026.

Is Panama Petrochem a good investment ahead of Q4 results?

Panama Petrochem at Rs 315 offers a risk-reward contingent on Q4 execution and FY27 guidance. Investors should review analyst estimates, monitor the results announcement, and consult a SEBI-registered advisor before making investment decisions.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook